Timing to completionremains a risk. Assuming payment late Dec, I'd still buy up to ~HK$4.30/share, for a 7%/20% gross/annualised return. Pushback? I'm too aggressive with my timetable.
What is covered in the Full Insight:
Introduction
Profit Warning Details
Sinopharm's Involvement
Conclusion and Trade Recommendations
Offer Recap and Data
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.